WIM
ACXP icon

Westside Investment Management’s Acurx Pharmaceuticals ACXP Stock Holding History

Westside Investment Management’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56K Hold
1,650
– – ﹤0.01% 1307
2026
Q1 		$6.12K Buy
+1,650
New +$4.68K ﹤0.01% 1219

Other funds holding ACXP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PFS
Prospect Financial Services Melville, New York $197M AUM 24.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Westside Investment Management's ACXP Position: Q2 2026 in Review

Westside Investment Management held its Acurx Pharmaceuticals (ACXP) position steady in Q2 2026 at 1,650 shares worth $2.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

Westside Investment Management first reported a position in ACXP in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.12K in Q1 2026. 19 funds tracked by Wall St. Rank hold ACXP as of Q2 2026.

  • Westside Investment Management held 1,650 shares of Acurx Pharmaceuticals worth $2.56K as of Q2 2026.
  • Westside Investment Management left its Acurx Pharmaceuticals share count unchanged in Q2 2026.
  • Acurx Pharmaceuticals made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2026, its #1307 holding.
  • Westside Investment Management first reported a position in Acurx Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Westside Investment Management's Acurx Pharmaceuticals position peaked at $6.12K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.